z-logo
open-access-imgOpen Access
Glutamate, Interleukin-6, and Early Clinical Worsening in Patients With Acute Stroke
Author(s) -
Nicolás Vila,
Ángel Chamorro,
José Castillo,
Antonio Dávalos
Publication year - 2001
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.32.5.1234-a
Subject(s) - medicine , stroke (engine) , acute stroke , interleukin , cardiology , intensive care medicine , cytokine , tissue plasminogen activator , mechanical engineering , engineering
To the Editor: We appreciate Dr Christensen’s interest in our work, recently published in Stroke .1 As we stated in the Subjects and Methods section of that article, the 231 patients analyzed in our study were selected form a larger cohort of 249 patients admitted consecutively between October 1992 and December 1996. Shrewdly, Christensen correctly guesses that this larger cohort includes the 128 patients that supported our report on glutamate excitotoxicity in acute ischemic stroke.2 Therefore, this larger series gives additional ground and further credit to the role of glutamate and IL-6 on neurological deterioration in patients with ischemic stroke.The concentrations …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom